Filed: 8/13/2024ACC: 0000904454-24-000458
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $352.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$352.29M
Total AUM (reported)
16.70M
Total Shares
Allocation by class
COM$128.42M36.5%
COM SER C$109.34M31.0%
SPONSORED ADR$49.05M13.9%
COM NEW$25.52M7.2%
CLASS A ORD$17.10M4.9%
SPON ADR$13.45M3.8%
SHS$8.95M2.5%
Portfolio Concentration
Top 3$163.46M46.4%
4–10$129.97M36.9%
11–25$58.85M16.7%
Top 3 weight
46.4%
Top 10 weight
83.3%
Voting Authority Distribution
Total shares with voting rights: 16.70M
Sole
Full voting authority
16.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
LIBERTY BROADBAND CORP
SOLEShares1.99M
TypeSH
Market value$109.34M
31.04%
Sole
1.99M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares729.46K
TypeSH
Market value$28.31M
8.04%
Sole
729.46K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares189.27K
TypeSH
Market value$25.81M
7.33%
Sole
189.27K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares638.35K
TypeSH
Market value$24.05M
6.83%
Sole
638.35K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares54.03K
TypeSH
Market value$23.23M
6.60%
Sole
54.03K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares132.84K
TypeSH
Market value$20.99M
5.96%
Sole
132.84K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares388.83K
TypeSH
Market value$17.10M
4.85%
Sole
388.83K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares574.38K
TypeSH
Market value$15.29M
4.34%
Sole
574.38K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares905.38K
TypeSH
Market value$14.71M
4.18%
Sole
905.38K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1.78M
TypeSH
Market value$14.60M
4.15%
Sole
1.78M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares256.45K
TypeSH
Market value$13.89M
3.94%
Sole
256.45K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares542.76K
TypeSH
Market value$13.45M
3.82%
Sole
542.76K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares1.61M
TypeSH
Market value$10.47M
2.97%
Sole
1.61M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares433.47K
TypeSH
Market value$8.95M
2.54%
Sole
433.47K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares707.40K
TypeSH
Market value$6.15M
1.75%
Sole
707.40K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$5.45M
1.55%
Sole
961.25K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VII
SOLEShares548K
TypeSH
Market value$191.8K
0.05%
Sole
548K
Shared
0.00
None
0.00
MONEYHERO LIMITED
SOLEShares895K
TypeSH
Market value$71.6K
0.02%
Sole
895K
Shared
0.00
None
0.00
CONCORD ACQUISITION CORP II
SOLEShares408.33K
TypeSH
Market value$44.9K
0.01%
Sole
408.33K
Shared
0.00
None
0.00
SWIFTMERGE ACQUISITION CORP
SOLEShares490K
TypeSH
Market value$39.2K
0.01%
Sole
490K
Shared
0.00
None
0.00
LAKESHORE BIOPHARMA CO LTD
SOLEShares490K
TypeSH
Market value$33.4K
<0.01%
Sole
490K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares655.20K
TypeSH
Market value$27.6K
<0.01%
Sole
125K
Shared
0.00
None
0.00
COMPASS DIGITAL ACQUISITION CORP
SOLEShares459.91K
TypeSH
Market value$27.5K
<0.01%
Sole
459.91K
Shared
0.00
None
0.00
MARBLEGATE ACQUISITION CORP
SOLEShares735K
TypeSH
Market value$26.8K
<0.01%
Sole
735K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$25.0K
<0.01%
Sole
655.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIBERTY BROADBAND CORPSOLE | COM SER C | 1.99M | SH | $109.34M 31.04% | 1.99M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 729.46K | SH | $28.31M 8.04% | 729.46K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 189.27K | SH | $25.81M 7.33% | 189.27K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 638.35K | SH | $24.05M 6.83% | 638.35K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 54.03K | SH | $23.23M 6.60% | 54.03K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 132.84K | SH | $20.99M 5.96% | 132.84K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 388.83K | SH | $17.10M 4.85% | 388.83K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 574.38K | SH | $15.29M 4.34% | 574.38K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 905.38K | SH | $14.71M 4.18% | 905.38K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 1.78M | SH | $14.60M 4.15% | 1.78M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 256.45K | SH | $13.89M 3.94% | 256.45K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 542.76K | SH | $13.45M 3.82% | 542.76K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 1.61M | SH | $10.47M 2.97% | 1.61M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 433.47K | SH | $8.95M 2.54% | 433.47K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 707.40K | SH | $6.15M 1.75% | 707.40K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $5.45M 1.55% | 961.25K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VIISOLE | *W EXP 02/29/202 | 548K | SH | $191.8K 0.05% | 548K | 0.00 | 0.00 |
MONEYHERO LIMITEDSOLE | *W EXP 09/13/202 | 895K | SH | $71.6K 0.02% | 895K | 0.00 | 0.00 |
CONCORD ACQUISITION CORP IISOLE | *W EXP 99/99/999 | 408.33K | SH | $44.9K 0.01% | 408.33K | 0.00 | 0.00 |
SWIFTMERGE ACQUISITION CORPSOLE | *W EXP 12/13/202 | 490K | SH | $39.2K 0.01% | 490K | 0.00 | 0.00 |
LAKESHORE BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 490K | SH | $33.4K <0.01% | 490K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | *W EXP 03/14/202 | 655.20K | SH | $27.6K <0.01% | 125K | 0.00 | 0.00 |
COMPASS DIGITAL ACQUISITION CORPSOLE | *W EXP 09/29/202 | 459.91K | SH | $27.5K <0.01% | 459.91K | 0.00 | 0.00 |
MARBLEGATE ACQUISITION CORPSOLE | *W EXP 08/31/202 | 735K | SH | $26.8K <0.01% | 735K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | COM NEW | 125K | SH | $25.0K <0.01% | 655.20K | 0.00 | 0.00 |